IL318162A - Deuterated pyrimidin-2-yl sulfonamide derivatives - Google Patents

Deuterated pyrimidin-2-yl sulfonamide derivatives

Info

Publication number
IL318162A
IL318162A IL318162A IL31816225A IL318162A IL 318162 A IL318162 A IL 318162A IL 318162 A IL318162 A IL 318162A IL 31816225 A IL31816225 A IL 31816225A IL 318162 A IL318162 A IL 318162A
Authority
IL
Israel
Prior art keywords
deuterated
pyrimidin
sulfonamide derivatives
sulfonamide
derivatives
Prior art date
Application number
IL318162A
Other languages
Hebrew (he)
Inventor
Guido Galley
Luca Claudio Gobbi
Wolfgang Guba
Dmitry Mazunin
Emmanuel Pinard
Original Assignee
Hoffmann La Roche
Guido Galley
Luca Claudio Gobbi
Wolfgang Guba
Dmitry Mazunin
Emmanuel Pinard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Guido Galley, Luca Claudio Gobbi, Wolfgang Guba, Dmitry Mazunin, Emmanuel Pinard filed Critical Hoffmann La Roche
Publication of IL318162A publication Critical patent/IL318162A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL318162A 2022-08-26 2023-08-24 Deuterated pyrimidin-2-yl sulfonamide derivatives IL318162A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22192252 2022-08-26
PCT/EP2023/073189 WO2024042147A2 (en) 2022-08-26 2023-08-24 Novel deuterated pyrimidin-2-yl sulfonamide derivatives

Publications (1)

Publication Number Publication Date
IL318162A true IL318162A (en) 2025-03-01

Family

ID=83081337

Family Applications (1)

Application Number Title Priority Date Filing Date
IL318162A IL318162A (en) 2022-08-26 2023-08-24 Deuterated pyrimidin-2-yl sulfonamide derivatives

Country Status (16)

Country Link
US (1) US20250188061A1 (en)
EP (1) EP4577538A2 (en)
JP (1) JP2025527937A (en)
KR (1) KR20250052376A (en)
CN (1) CN119731168A (en)
AR (1) AR130300A1 (en)
AU (1) AU2023329097A1 (en)
CA (1) CA3262954A1 (en)
CL (1) CL2025000484A1 (en)
CO (1) CO2025003256A2 (en)
CR (1) CR20250058A (en)
IL (1) IL318162A (en)
MX (1) MX2025001765A (en)
PE (1) PE20251077A1 (en)
TW (1) TW202417424A (en)
WO (1) WO2024042147A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025243044A1 (en) 2024-05-23 2025-11-27 Pheno Therapeutics Limited Compounds
GB2700773A (en) 2024-05-23 2026-03-11 Pheno Therapeutics Ltd Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI857957B (en) * 2018-06-19 2024-10-11 德商Ucb製藥有限公司 Pyridinyl and pyrazinyl-(aza)indolsulfonamides
EP3584244A1 (en) * 2018-06-20 2019-12-25 UCB Pharma GmbH Substituted alkoxypyridinyl indolsulfonamides
JP2022517797A (en) * 2019-01-17 2022-03-10 アイエフエム デュー インコーポレイテッド Compounds and compositions for treating conditions associated with STING activity

Also Published As

Publication number Publication date
CA3262954A1 (en) 2024-02-29
KR20250052376A (en) 2025-04-18
WO2024042147A3 (en) 2024-05-16
JP2025527937A (en) 2025-08-25
MX2025001765A (en) 2025-05-02
US20250188061A1 (en) 2025-06-12
CL2025000484A1 (en) 2025-06-27
CN119731168A (en) 2025-03-28
AU2023329097A1 (en) 2024-11-21
EP4577538A2 (en) 2025-07-02
CR20250058A (en) 2025-05-09
PE20251077A1 (en) 2025-04-10
TW202417424A (en) 2024-05-01
WO2024042147A2 (en) 2024-02-29
CO2025003256A2 (en) 2025-04-16
AR130300A1 (en) 2024-11-27

Similar Documents

Publication Publication Date Title
IL304450A (en) Novel pyrimidin-2-yl sulfonamide derivatives
DK4139309T5 (en) [1,3]DIAZINO[5,4-D]PYRIMIDINES AS HER2 INHIBITORS
GB2588470B (en) Pupil expansion
CA3262954A1 (en) Novel deuterated pyrimidin-2-yl sulfonamide derivatives
IL311050A (en) Deuterated empathogens
IL326686A (en) Lens designs
CA222122S (en) Rangefinder
ES3066535T3 (en) Levelling piece
IL310176A (en) Deuterated compounds
GB2594133B (en) Pupil expansion
CA222653S (en) Soap
CA220169S (en) Suitcase
GB2619771B (en) Suitcase
GB2603220B (en) Stable Antiviral Formulation
GB202201331D0 (en) Deuterated compounds
GB202103981D0 (en) Deuterated compounds
HK40111114A (en) Novel spiropyrrolidine derived antiviral agents
CA220795S (en) Vial
CA227049S (en) Soap
CA212829S (en) Belted towel
EM87971610001S (en) Cubicle walls; Luminaires
CA205919S (en) Face towel
GB202020756D0 (en) Bathroom mirror
HK40130368A (en) Deuterated compounds
CA3280572A1 (en) Deuterated compounds